StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)

Close on Nov 18, 2026Market cap $115.53MP/E –Yield –

Pulmonx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pulmonx's revenue for the twelve months ending Jun 30, 2026 was $87.44M, down 3.4% year over year. For fiscal 2025 it was $90.50M, up 8.0% from the year before. The highest annual figure on record is $90.50M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.50M+8.0%
FY2024Dec 31, 2024$83.79M+22.0%
FY2023Dec 31, 2023$68.68M+28.0%
FY2022Dec 31, 2022$53.66M+10.8%
FY2021Dec 31, 2021$48.42M+47.9%
FY2020Dec 31, 2020$32.73M+0.4%
FY2019Dec 31, 2019$32.60M+62.9%
FY2018Dec 31, 2018$20.00M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.76M-4.6%
Q1 FY2026Mar 31, 2026$20.59M-8.7%
Q4 FY2025Dec 31, 2025$22.60M-4.9%
Q3 FY2025Sep 30, 2025$21.50M+5.5%
Q2 FY2025Jun 30, 2025$23.86M+14.8%
Q1 FY2025Mar 31, 2025$22.54M+19.5%
Q4 FY2024Dec 31, 2024$23.77M+23.3%
Q3 FY2024Sep 30, 2024$20.39M+15.4%
Q2 FY2024Jun 30, 2024$20.78M+20.9%
Q1 FY2024Mar 31, 2024$18.85M+29.7%
Q4 FY2023Dec 31, 2023$19.28M+25.0%
Q3 FY2023Sep 30, 2023$17.67M+30.9%
Q2 FY2023Jun 30, 2023$17.19M+23.3%
Q1 FY2023Mar 31, 2023$14.54M+34.8%
Q4 FY2022Dec 31, 2022$15.43M+12.5%
Q3 FY2022Sep 30, 2022$13.50M+1.8%
Q2 FY2022Jun 30, 2022$13.95M+14.3%
Q1 FY2022Mar 31, 2022$10.79M+16.7%
Q4 FY2021Dec 31, 2021$13.71M+39.5%
Q3 FY2021Sep 30, 2021$13.26M+25.0%
Q2 FY2021Jun 30, 2021$12.20M+232.2%
Q1 FY2021Mar 31, 2021$9.24M+7.3%
Q4 FY2020Dec 31, 2020$9.83M-5.0%
Q3 FY2020Sep 30, 2020$10.61M+16.6%
Q2 FY2020Jun 30, 2020$3.67M-50.1%
Q1 FY2020Mar 31, 2020$8.62M+49.2%
Q4 FY2019Dec 31, 2019$10.35M–
Q3 FY2019Sep 30, 2019$9.10M–
Q2 FY2019Jun 30, 2019$7.37M–
Q1 FY2019Mar 31, 2019$5.78M–

More Pulmonx figures

See a number that looks wrong?